menu search

Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023

Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023
Conference call and live audio webcast scheduled for Monday, January 30th at 4:30 p.m. ET BEDMINSTER, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, today announced that the Company […] The post Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023 a... Read More
Posted: Jan 23 2023, 12:00
Author Name: forextv
Views: 102538

Search within

Pages Search Results: